Biomea Fusion (BMEA.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec17

Biomea Fusion Announces Presentation at the 44th Annual J.P. Morgan Healthcare Conference

12:51

Dec15

Biomea Fusion executive purchases 30,000 shares of company stock

00:00

Dec14

Biomea Fusion to participate in the BIO International Convention 2026

15:42

Biomea Fusion's Food Effect Study (COVALENT-121) is expected to be completed by the end of December 2025.

13:31

Biomea Fusion expects to announce initial clinical data for its next-generation oral GLP-1 receptor agonist, BMF-650, in the first half of 2026.

13:31

D. Boral Capital maintains a Buy rating on Biomea Fusion but lowers the price target to $12 from $16.

10:39

Schedules & Filings

Schedules

Filings

Nov4

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -16.41 M, EPS -0.2741

Aug5

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -20.74 M, EPS -0.5104

May5

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -29.26 M, EPS -0.7989

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change